On 2 November 2017
Natco Pharma will hold a meeting of the Board of Directors of the Company on 2 November 2017, for approval of the unaudited financial results, both on standalone and consolidated basis for the quarter and half-year ended 30th September, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
